Biosecurity Experts Describe How Congress Can Help Prepare for Bioterrorism Attacks

Developers of medical countermeasures against biological agents are frustrated by a lack of sufficient product development funding and the slow, overly cautious federal contracting process, policy expert Brad Smith said at a congressional briefing organized by AAAS."Preparation matters," said Smith, listing pharmaceutical treatments and vaccines, public awareness and a health care system that can handle epidemics as essential components to managing a bioterrorism attack. "All of these things take a long time to put in place."

By AAAS, USA.

Health Policy Resource.